Skip to main content

Table 6

From: The timing of administering aspirin and nitroglycerin in patients with STEMI ECG changes alter patient outcome

  Improvenents in exclusive STEMI group (2404 patients) over the whole cohort of 2594 patients
1 - Figure 1a improved by 2.4% meaning less 3rd nitroglycerin’s were given in A9 compared to A1 (compared to whole cohort analysis)
2 Figure 1b improved by 2.16% meaning more patients received only 1 nitroglycerin in group A9 compared to A1 (job was done with 1 nitroglycerin). (compared to whole cohort analysis)
3 Figure 2a improved by 0.76% meaning more patients were feeling better (+) than same (0) in A9 compared to A1 in the combined 1st and 2nd nitroglycerin group. (compared to whole cohort analysis)
4 Figure 2b was reduced by 1.3% meaning less patients were felling same (0), or more patients reported better (+) in A9 compared to A1 in the combined 3rd and the rest group. (compared to whole cohort analysis)